DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

PB Fintech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 10:58 am

PB Fintech

PB Fintech Limited has informed stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations. This document confirms that the company has successfully complied with the specific regulatory requirements for its securities, including shares and warrants, held in dematerialized (demat) form.

For investors, this development is a procedural milestone that validates the integrity of PB Fintech's shareholding structure. It confirms that the company's shares are eligible for trading and settlement, which is a standard prerequisite for maintaining a healthy and compliant market presence.

Investors should note that this is a routine regulatory filing. The focus now shifts to the company's execution of its business strategy and its ability to maintain compliance with ongoing regulatory obligations.